ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,585.59
(
0.8%
)
US Tech 100
15,612.00
(
1.36%
)
Dow Jones
36,117.38
(
0.17%
)
Brent Oil
75.695
(
1.42%
)
Bitcoin
43,451.01
(
0.35%
)
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seres Therapeutics Inc (MCRB)

  7. Seres Therapeutics Inc (MCRB) News

MCRB Seres Therapeutics Inc

1.11
0.03 (2.78%)
Dec 07 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Seres Therapeutics Inc MCRB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.03 2.78% 1.11 19:58:22
Open Price Low Price High Price Close Price Prev Close
1.11 1.07 1.14 1.10 1.08
more quote information »

Recent News

Date Time Source Heading
12/07/202319:46BWSeres Therapeutics Announces Presentation of Preliminary..
11/28/202309:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
11/27/202319:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
11/21/202306:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
11/02/202310:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202307:05EDGAR2Form 8-K - Current report
11/02/202307:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
11/01/202310:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
10/31/202321:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202321:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202321:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202321:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202317:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
10/12/202307:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
10/06/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10/04/202307:00EDGAR2Form 8-K - Current report
9/11/202306:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
9/08/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
9/07/202310:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
8/29/202309:00PRNUSInvaio achieves first registration for citrus greening..
8/16/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/08/202316:07EDGAR2Form S-3 - Registration statement under Securities Act of..
8/08/202310:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:05EDGAR2Form 8-K - Current report
8/08/202307:00BWSeres Therapeutics Reports Second Quarter 2023 Financial..
8/04/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
8/01/202307:00BWSeres Therapeutics to Present at Canaccord Genuity 43rd..
7/14/202316:01BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
6/21/202309:00BWSeres Therapeutics Named to TIME100 Most Influential..
6/17/202315:45BWSeres Therapeutics and Nestlé Health Science Present..
6/09/202307:00BWSeres Therapeutics to Present at Goldman Sachs Global..
6/05/202307:00BWSeres Therapeutics and Nestlé Health Science Announce U.S...
6/02/202307:00BWSeres Therapeutics to Present at Jefferies Healthcare..
5/30/202316:00BWSeres Therapeutics Announces Receipt of $125 Million..
5/16/202306:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..
5/10/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
5/09/202307:00BWSeres Therapeutics Reports First Quarter 2023 Financial..
5/08/202307:00BWSeres Therapeutics and Nestlé Health Science Present Results..
5/05/202307:00BWSeres Therapeutics to Host First Quarter 2023 Financial..
4/27/202307:00BWSeres Therapeutics Announces $250 Million Debt Financing..
4/26/202319:46BWSeres Therapeutics and Nestlé Health Science Announce FDA..
4/07/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
3/09/202307:00BWSeres Therapeutics to Participate in Oppenheimer 33rd Annual..
3/07/202307:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2022..
3/03/202316:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
2/28/202307:00BWSeres Therapeutics to Host Fourth Quarter 2022 Financial..
2/27/202307:00BWSeres Therapeutics to Participate in Cowen 43rd Annual..
2/14/202307:00BWSeres Therapeutics’ Investigational SER-109 ECOSPOR IV Study..

Your Recent History

NASDAQ
MCRB
Seres Therapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com